ISRCTN ISRCTN12983121
DOI https://doi.org/10.1186/ISRCTN12983121
IRAS number 339900
Secondary identifying numbers EDGE 173654, CPMS 66642
Submission date
19/05/2025
Registration date
20/05/2025
Last edited
16/07/2025
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Time is critical in trauma care. Delays, even minutes, can significantly affect outcomes, especially in patients with life-threatening bleeding. This study tests a real-time digital handover system to improve how trauma teams receive patient information from London’s Air Ambulance, aiming to reduce delays in treatment for seriously injured patients. The system helps transmit key patient information (injury details, vital signs, treatments) directly from the ambulance team to the hospital before the patient arrives.

Who can participate?
Trauma clinicians (doctors, registrars, paramedics) and trauma patients aged 16 years and over

What does the study involve?
Clinicians complete a risk perception questionnaire after each trauma case, fill out a usability questionnaire every 2 months and take part in interviews to give feedback on system use and impact. There is no direct patient intervention - only data from standard care used with consent.

What are the possible benefits and risks of participating?
The findings will inform the development of a clinical decision support system using AI and lead to future trials focused on improving trauma care efficiency and outcomes. Patient and clinician data will be anonymised and securely stored. There are no changes to current patient care or treatment.

Where is the study run from?
Queen Mary University London (UK)

When is the study starting and how long is it expected to run for?
February 2025 to November 2025

Who is funding the study?
1. Rosetrees Trust (UK)
2. ZOLL Medical Corporation

Who is the main contact?
Dr Zane Perkins, z.perkins@qmul.ac.uk

Contact information

Dr Zane Perkins
Public, Scientific, Principal Investigator

Centre for Trauma Sciences
Blizard Institute
Queen Mary University of London
4 Newark Street
London
E1 2AT
United Kingdom

Phone +44 (0)2073777000
Email z.perkins@qmul.ac.uk

Study information

Study designProspective observational mixed-methods study
Primary study designObservational
Secondary study designProspective qualitative study
Study setting(s)Hospital, Paramedicine
Study typeOther, Safety, Efficacy
Participant information sheet Not available in web format
Scientific titleDigital decision support to reduce time to treatment in trauma
Study objectives1. To implement and evaluate a real-time digital handover system, to streamline the transition of care from the pre-hospital setting to the major trauma centre (secondary care).
2. To assess the accuracy of experienced clinicians in evaluating significant risks in trauma patients.
Ethics approval(s)

Approved 24/02/2025, Health and Social Care Research Ethics Committee B (HSC REC B) (Office for Research Ethics Committees Northern Ireland (ORECNI), Lissue Industrial estate West, 5 Rathdown Walk, Lisburn, BT28 2RF, United Kingdom; +44 (0)28 95361400; info.orecni@hscni.net), ref: 25/NI/0019

Health condition(s) or problem(s) studiedTraumatic injury
InterventionThe study comprises a mixed methodology approach with five components:
1. Clinical risk perception questionnaire
2. Clinician usability questionnaire
3. Semi-structured clinician interview
4. Quantitative evaluation
5. Hazard analysis

Clinicians complete a risk perception questionnaire after each trauma case, fill out a usability questionnaire every 2 months and take part in interviews to give feedback on system use and impact. There is no direct patient intervention - only data from standard care used with consent.
Intervention typeOther
Primary outcome measure1. Usability measured by the System Usability Scale score and the PAAS Mental Effort Scale at each trauma team activation
2. Perceived usefulness and acceptability based on a semi-structured interview at 2-monthly intervals (beginning, middle, and end of study)
Secondary outcome measures1. Clinician risk perception: clinicians’ estimates of patient risks will be measured using a 0-100% probability scale immediately post-resuscitation
2. Clinician risk perception performance: clinician risk estimates will be compared to documented (true) patient outcomes to assess accuracy
3. The patient risks and outcomes that will be measured are:
3.1. In-hospital mortality
3.2. Trauma-induced coagulopathy (TIC), defined as an admission Prothrombin Time ratio (PTr) >1.2
3.3. Significant haemorrhage (≥4 units of blood transfused within 4 hours post-injury)
The patient outcome data used for comparisons are standard clinical indicators routinely collected during trauma care. This study will not involve any additional data collection directly from patients. Instead, it will utilise retrospective data analysis of existing clinical records to determine the accuracy of clinicians' risk assessments.
Overall study start date24/02/2025
Completion date30/11/2025

Eligibility

Participant type(s)Patient, Health professional
Age groupAdult
Lower age limit16 Years
SexBoth
Target number of participants60 trauma clinicians across 300 activations by Londons Air Ambulance
Key inclusion criteria1. Trauma clinicians:
Consultant, Specialist Registrar (resident), or paramedics who have direct involvement in initial assessment, management of adult trauma patients transported by London's Air Ambulance to the Royal London Hospital.

2. Trauma patients:
Aged 16 years or over with traumatic injury
Key exclusion criteriaTrauma clinicians:
1. Consent: clincians who decline to consent or participate
2. Involvement: clinicians not involved in the initial care of adult trauma patients

Trauma patients:
1. Aged under 16 years
2. Presenting with injuries: burns, hangings, drownings, or acute psychotic episodes without physical injuries
Date of first enrolment01/05/2025
Date of final enrolment31/07/2025

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Barts and the London NHS Trust
Alexandra House
The Royal London Hospital
Whitechapel
London
E1 1BB
United Kingdom

Sponsor information

Queen Mary University of London
University/education

JRMO
Research Services
Dept. W
69-89 Mile End Road
London
E1 4UJ
England
United Kingdom

Phone +44 (0)2078827275/6574
Email research.governance@qmul.ac.uk
Website http://www.qmul.ac.uk/
ROR logo "ROR" https://ror.org/026zzn846

Funders

Funder type

Charity

Rosetrees Trust
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Teresa Rosenbaum Golden Charitable Trust, Rosetrees
Location
United Kingdom
ZOLL Medical Corporation
Private sector organisation / For-profit companies (industry)
Alternative name(s)
ZOLL, Zoll Medical Corp., ZOLL Medical, ZMC
Location
United States of America

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in non-publicly available repository
Publication and dissemination planThe results will be disseminated through:
1. Presentations at academic conferences
2. Integration into student academic work, including dissertations and theses
3. Publications in peer-reviewed journals
IPD sharing planAll data from clinician participants within the study will be fully anonymised. Routine clinical outcome data will be retrospectively captured from Bart's Health NHS trust electronic healthcare records. Patient-level data will be pseudo-anonymised and assigned an identifier case record number prior to full anonymisation.

The datasets generated during and/or analysed during the current study will be stored in a non-publicly available repository - Barts Cancer Centre Information Technology infrastructure - Safe Haven.

Editorial Notes

16/07/2025: The completion date was changed from 31/10/2025 to 30/11/2025.
01/07/2025: Internal review.
19/05/2025: Study's existence confirmed by Health and Social Care Research Ethics Committee B.